US Stock MarketDetailed Quotes

AMMCF CRISM THERAPEUTICS CORPORATION

Watchlist
  • 0.042
  • 0.0000.00%
15min DelayClose Dec 16 09:30 ET
1.38MMarket Cap0.00P/E (TTM)

CRISM THERAPEUTICS CORPORATION Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
(FY)Dec 31, 2017
(FY)Dec 31, 2016
(FY)Dec 31, 2015
(FY)Dec 31, 2014
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Cash from discontinued investing activities
Investing cash flow
Cash flow from continuing investing activities
Capital expenditure reported
----
----
----
----
----
----
----
----
----
64.70%-480.58K
Net PPE purchase and sale
--0
--0
23.73%-315.64K
-8.31%-413.85K
76.36%-382.1K
41.03%-1.62M
25.40%-2.74M
-97.86%-3.67M
---1.86M
--0
Net investment purchase and sale
----
----
--4.55M
--0
----
----
----
----
----
----
Net other investing changes
6,593.98%27.42M
---422.24K
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
6,593.98%27.42M
-109.44%-422.24K
217.73%4.47M
-896.54%-3.8M
76.40%-381.34K
41.01%-1.62M
25.39%-2.74M
-97.68%-3.67M
-286.39%-1.86M
65.77%-480.58K
Financing cash flow
Cash flow from continuing financing activities
Net issuance payments of debt
----
----
----
68.30%-82.92K
-109.61%-261.6K
--2.72M
--0
----
----
----
Net common stock issuance
--0
--285.08K
--0
421.72%7.34M
--1.41M
--0
-92.10%421.78K
118.68%5.34M
--2.44M
--0
Cash dividends paid
---24.69M
----
----
----
----
----
----
----
----
----
Net other financing activities
----
--514.79K
----
----
----
----
----
----
515.69%7.28M
-19.07%1.18M
Cash from discontinued financing activities
Financing cash flow
-3,186.21%-24.69M
--799.87K
--0
533.62%7.26M
-57.92%1.15M
545.36%2.72M
-92.10%421.78K
-45.08%5.34M
722.16%9.72M
-54.02%1.18M
Net cash flow
Beginning cash position
-48.48%2.84M
167.09%5.52M
607.85%2.07M
-69.54%292.04K
-52.39%958.69K
-66.81%2.01M
-22.13%6.07M
731.02%7.79M
-38.99%937.56K
23.74%1.54M
Current changes in cash
122.18%560.48K
-181.10%-2.53M
68.70%3.12M
369.07%1.85M
26.31%-686.41K
78.42%-931.51K
-3,450.88%-4.32M
-102.10%-121.58K
1,138.00%5.78M
-347.58%-557.03K
Effect of exchange rate changes
--36.11K
--0
-152.85%-231.91K
-393.32%-91.72K
134.21%31.27K
-165.02%-91.42K
113.72%140.59K
-343.79%-1.02M
-164.20%-230.85K
-433.65%-87.38K
End cash Position
14.92%3.44M
-39.52%2.99M
141.84%4.95M
574.43%2.05M
-69.36%303.55K
-47.60%990.62K
-71.55%1.89M
2.41%6.65M
627.10%6.49M
-38.48%892.4K
Free cash flow
25.14%-2.17M
-73.53%-2.9M
17.35%-1.67M
-10.50%-2.03M
49.85%-1.83M
22.92%-3.65M
13.25%-4.74M
-38.62%-5.47M
-126.61%-3.94M
25.89%-1.74M
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018(FY)Dec 31, 2017(FY)Dec 31, 2016(FY)Dec 31, 2015(FY)Dec 31, 2014
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Cash from discontinued investing activities
Investing cash flow
Cash flow from continuing investing activities
Capital expenditure reported ------------------------------------64.70%-480.58K
Net PPE purchase and sale --0--023.73%-315.64K-8.31%-413.85K76.36%-382.1K41.03%-1.62M25.40%-2.74M-97.86%-3.67M---1.86M--0
Net investment purchase and sale ----------4.55M--0------------------------
Net other investing changes 6,593.98%27.42M---422.24K--------------------------------
Cash from discontinued investing activities
Investing cash flow 6,593.98%27.42M-109.44%-422.24K217.73%4.47M-896.54%-3.8M76.40%-381.34K41.01%-1.62M25.39%-2.74M-97.68%-3.67M-286.39%-1.86M65.77%-480.58K
Financing cash flow
Cash flow from continuing financing activities
Net issuance payments of debt ------------68.30%-82.92K-109.61%-261.6K--2.72M--0------------
Net common stock issuance --0--285.08K--0421.72%7.34M--1.41M--0-92.10%421.78K118.68%5.34M--2.44M--0
Cash dividends paid ---24.69M------------------------------------
Net other financing activities ------514.79K------------------------515.69%7.28M-19.07%1.18M
Cash from discontinued financing activities
Financing cash flow -3,186.21%-24.69M--799.87K--0533.62%7.26M-57.92%1.15M545.36%2.72M-92.10%421.78K-45.08%5.34M722.16%9.72M-54.02%1.18M
Net cash flow
Beginning cash position -48.48%2.84M167.09%5.52M607.85%2.07M-69.54%292.04K-52.39%958.69K-66.81%2.01M-22.13%6.07M731.02%7.79M-38.99%937.56K23.74%1.54M
Current changes in cash 122.18%560.48K-181.10%-2.53M68.70%3.12M369.07%1.85M26.31%-686.41K78.42%-931.51K-3,450.88%-4.32M-102.10%-121.58K1,138.00%5.78M-347.58%-557.03K
Effect of exchange rate changes --36.11K--0-152.85%-231.91K-393.32%-91.72K134.21%31.27K-165.02%-91.42K113.72%140.59K-343.79%-1.02M-164.20%-230.85K-433.65%-87.38K
End cash Position 14.92%3.44M-39.52%2.99M141.84%4.95M574.43%2.05M-69.36%303.55K-47.60%990.62K-71.55%1.89M2.41%6.65M627.10%6.49M-38.48%892.4K
Free cash flow 25.14%-2.17M-73.53%-2.9M17.35%-1.67M-10.50%-2.03M49.85%-1.83M22.92%-3.65M13.25%-4.74M-38.62%-5.47M-126.61%-3.94M25.89%-1.74M
Currency Unit GBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.